Abstract
Oxidative stress and mitochondrial dysfunction are implicated in neuronal apoptosis associated with Huntington’s disease. Naringin is the flavanone present in grapefruit and related citrus species possess diverse pharmacological and therapeutic properties including antioxidant, anti-apoptotic, and neuroprotective properties. The aim of this study was to investigate the protective effect of naringin on 3-nitropropionic acid (3-NP)-induced neurotoxicity in pheochromocytoma cells (PC12) cells and to explore its mechanism of action. Naringin protects PC12 cells from 3-NP neurotoxicity, as evaluated the by cell viability assays. The lactate dehydrogenase release was decreased upon naringin treatment in 3-NP-induced PC12 cells. Naringin treatment enhances the antioxidant defense by increasing the activities of enzymatic antioxidants and the level of reduced glutathione. The increase in levels of reactive oxygen species and lipid peroxidation induced by 3-NP were significantly decreased by naringin. PC12 cells induced with 3-NP showed decrease in the mitochondrial membrane potential and mitochondrial respiratory complex enzymes, succinate dehydrogenase and cytochrome c oxidase activities, and it was significantly altered to near normal upon naringin treatment. Naringin reduced the 3-NP-induced apoptosis through the modulation in expressions of B-cell lymphoma 2 and Bcl-2-associated X protein. Further, naringin enhances the nuclear translocation of Nrf2 and induces the NAD(P)H:quinone oxidoreductase-1 and Heme oxygenase-1 expressions through the phosphatidylinositol-3-kinase (PI3K)/Akt signaling pathway. Taken together, the above findings suggest that naringin augments cellular antioxidant defense capacity and reduces the 3-NP-induced neurotoxicity in PC12 cells through the PI-3K/Akt-dependent Nrf2 activation in PC12 cells.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
3-Nitropropionic acid (3-NP) is a neurotoxin produced by numerous fungal species and naturally exists in leguminous plants. 3-NP inhibits the mitochondrial enzyme succinate dehydrogenase, involved in both electron transport chain and the tricarboxylic acid cycle [1]. 3-NP has been shown to be responsible for the neurodegeneration caused in human—by the ingestion of sugar cane, corn, and peanuts contaminated by Arthrinium fungi [2]. Huntington’s disease (HD) is an autosomal dominant, inherited neurodegenerative disorder, clinically characterized by involuntary choreic movements, cognitive impairment, and dementia [3]. 3-NP can induce biochemical and pathological changes and also selective striatal lesions in rats and non-human primates, mimicking those in HD [4, 5].
Mitochondria play significant role in the process of apoptosis and also in neurodegeneration [6]. Both HD and 3-NP neurotoxicity are characterized by the functional impairment of mitochondrial complex II [1, 7]. Disruption of mitochondrial activity is associated with the abnormal production of reactive oxidative species (ROS) like superoxide radical, hydrogen peroxide, hydroxyl radical, peroxyl radical and peroxynitrite, thereby generating oxidative stress [8]. Oxidative stress has been shown to be associated with the progression of striatal-lesion; a major pathological feature of HD [9]. ROS in turn renders mitochondria susceptible to oxidative damage. Mitochondrial dysfunction caused by ROS-induced oxidative damage has been shown to involve in the development of apoptotic cell death in HD as well as in 3-NP toxicity [10, 11].
Nuclear factor erythroid 2-related factor 2 (Nrf2) is a redox-sensitive transcription factor. Nrf2 is a key regulator in the coordinated induction of numerous cytoprotective and endogenous antioxidant genes and controls the physiological and pathophysiological perturbations of oxidants [12]. Under basal conditions, Nrf2 is anchored in the cytoplasm through binding to Kelch-like ECH-associated protein 1 (Keap1), and is maintained at a low level by proteasomal degradation. During oxidative stress, Nrf2 dissociates from Keap1 and translocates into nucleus and elicits the antioxidant response by the induction of target gene products [13]. Nrf2 activation and consecutive cytoprotective gene induction stimulate the restoration of balance between oxidants and antioxidants during oxidative stress. Recently, numerous studies have demonstrated that activation of Nrf2 pathway can intensely attenuate multiple pathophysiological processes, including oxidative stress, mitochondrial dysfunction, and apoptosis [14, 15]. Interestingly, recent studies suggest that Nrf2 is regulated through phosphatidylinositol-3-kinase (PI3K)/Akt signaling pathway [16, 17]. Indeed, Nrf2 regulation by this kinase appears to be an important mechanism in Nrf2-mediated ARE activation.
Flavonoids are the most abundant polyphenolic substances in our diet, which is present in most of the plant [18]. Recent studies have suggested that the flavonoids exhibit protection against neurodegeneration [19, 20]. Naringin, a well-known flavanone glycoside of grape fruits, e.g., Citrus paradise, Citrus unshiu, and Citrus sinensis, has been reported to attenuate the oxidative stress, apoptosis, and inflammation, demonstrated to possess neuroprotective effect [21, 22]. Further, naringin has been reported to possess various biological and pharmacological properties including antioxidant, anti-carcinogenic, and anti-atherogenic properties [23–25]. In our earlier studies, we have demonstrated the naringin-mediated protection in 3-NP-induced neurodegeneration through the Nrf2 signaling pathway in rats [26, 27]. Further the naringin was previously reported to activate PI-3K/Akt signaling pathway [28]. However, the protective effect of naringin by the PI-3K/Akt-mediated Nrf2 activation in 3-NP-induced neurotoxicity in PC12 cells is not elucidated. The aim of the present study is to investigate the protective effect of naringin on 3-NP-induced neurotoxicity in PC12 cells through the PI-3K/Akt-dependent Nrf2 activation.
Materials and methods
Chemicals and reagents
PC12 cells were purchased from National Centre for Cell Science, Pune, India. Roswell Park Memorial Institute (RPMI) 1640 medium, trypsin–EDTA, l-glutamine, fetal bovine serum (FBS), horse serum, and antibiotics were purchased from Himedia Laboratories, Mumbai, India. Poly-l-lysine solution, 1-(4,5-dimethylthiazol-2-yl)-3,5-diphenylformazan (MTT), 2′,7′-dichlorofluorescin diacetate (DCFH2-DA), and 5, 5′, 6, 6′-tetrachloro-1, 1′, 3, 3′ tetraethylbenzimidazolylcarbocyanine iodide (JC-1) were purchased from Sigma-Aldrich Company, St. Louis, MO, USA. LY294002 was purchased from Life Technologies, Inc. All disposable wares used for cell culture including tissue culture flasks, 96 and 6-well plates were purchased from Tarsons Product Pvt. Ltd., Kolkata, India.
Cell culture
The PC12 cells were grown in poly-l-lysine-coated tissue culture flask in RPMI-1640 medium supplemented with 10 % heat-inactivated FBS and 5 % heat-inactivated horse serum, 1 % l-glutamine, and antibiotic solution containing 100 units/ml penicillin and 100 µg/ml streptomycin. Cultures were maintained at 37 °C in a humidified atmosphere containing 5 % CO2. For differentiation, cells were plated on poly-l-lysine-coated (10 µg/ml) dishes. The differentiation was induced 24 h after seeding by adding 50 ng/ml of nerve growth factor (NGF 2.5 S) and incubated for 4 days.
Experimental design
After arriving at a dose and the time-dependent cell death induced by 3-NP and an optimal dose at which naringin protects from cell death, the following experimental design was set up.
-
Group 1 Control treated with 0.1 % dimethyl sulfoxide (DMSO).
-
Group 2 3-Nitropropionic acid (15 mM).
-
Group 3 3-Nitropropionic acid (15 mM) + Naringin (dissolved in 0.1 % DMSO) treated (10 µM).
-
Group 4 Naringin alone (10 µM).
Cell viability assay
Cell viability was assessed by MTT method by Yuan et al. [29]. Briefly, 5 × 103 cells were plated in 96-well plates. The cells were incubated for 12 h under 5 % CO2, 95 % O2 at 37 °C. Then, media were removed and replaced with serum-free medium containing 1 % BSA for 24 h. After removing the BSA medium, cells were stimulated with 3-NP and were incubated with/without naringin. The control cells received 0.1 % DMSO. After 24 h, 100 µl of 0.5 % MTT stock solution was added to each well and then incubated at 37 °C for 4 h. After incubation, the culture medium was replaced with 100 µl of DMSO to solubilize formazan crystals. Proliferation was expressed as absorbance at 650 nm recorded with a microtiter plate reader. The amount of formazan produced was directly proportional to the number of metabolically active cells. The cell viability was calculated as percentage of viable cells and then plotted on a graph.
Biochemical assays
The activity of lactate dehydrogenase (LDH) was assayed by the method of King [30]. Superoxide dismutase (SOD) was assayed by the method of Marklund and Marklund [31]. Catalase (CAT) activity was assayed by the method of Sinha [32]. Glutathione peroxidase (GPx) was assayed by the method of Rotruck et al. [33]. Glutathione reductase (GR) was assayed by the method of Staal et al. [34]. Reduced glutathione (GSH) was determined by the method of Moron et al. [35]. The level of lipid peroxidation (LPO) was assayed by the method of Ohkawa et al. [36]. Mitochondrial fractions were isolated by the method of Moreadith and Fiskum [37]. The Complex II (succinate dehydrogenase) activity was assayed by Slater and Borner [38]. The Complex IV (cytochrome c oxidase) activity was assayed by Mutisya et al. [39].
Measurement of ROS
ROS was measured using the fluorescent probe H2DCF-DA. The PC12 cells (5.0 × 103 cells/well) were exposed to 3-NP (15 mM) in the presence or absence of naringin (10 µM) and incubated for 16 h. Briefly, after the corresponding treatments, cells were incubated with 5 μM H2DCF-DA for 30 min in dark. Fluorescence measurement was performed at the excitation wavelength of 495 nm and the emission wavelength of 530 nm in a spectrofluorometer. For each experiment, fluorometric measurements were performed in triplicate and expressed as fluorescence intensity units [40].
Measurement of mitochondrial membrane potential changes
Mitochondrial membrane potential determination (Δψ m) was measured using JC-1 as a probe according to the method of Dey and Moraes [41]. The PC12 cells were exposed to 3-NP (15 mM) in the presence or absence of naringin (10 µM) and incubated for 16 h. Briefly, after the corresponding treatments, cells were incubated with 10 µM JC-1 for 6 min at 37 °C. The fluorescence was measured at two different wavelengths. The ratio of the reading at 590 nm to the reading at 530 nm was considered as the relative Δψ m value.
Cytosolic and nuclear protein extraction
The extraction of cytosolic and nuclear fractions was performed in PC12 cells to assess the Nrf2 expression. Briefly, PC12 cells (8 × 106) were suspended in hypotonic buffer [10 mM HEPES (pH 7.9), 1.5 mM MgCl2, 10 mM KCl, 1 mM dithiothreitol] containing protease inhibitors, and their outer membranes were disrupted by homogenization, and then centrifuged at 10,000×g for 20 min to collect the supernatant containing cytosolic fraction. The resultant nuclear pellet was resuspended, homogenized, and incubated in nuclear extraction buffer [20 mM HEPES, 1.5 mM MgCl2, 0.42 M NaCl, 0.2 mM EDTA, 1 mM dithiothreitol, 25 % glycerol] containing the protease inhibitors and finally, centrifuged at 20,000×g for 5 min to collect supernatant as nuclear fraction [42].
Western blot analyses
Cytosolic or nuclear protein (50 μg) was separated by 12 % SDS–polyacrylamide gel and then transferred electrophoretically to a polyvinylidene fluoride membrane (Millipore, USA). The membrane was blocked with 5 % BSA and 0.1 % Tween-20 in Tris-buffered saline at room temperature for 2 h. The membrane was then incubated overnight with the rabbit polyclonal IgG Nrf2 (Santa Cruz Biotech, CA, USA) at 4 °C. Then, the membrane was washed thrice for 15 min and incubated with the secondary horseradish peroxidase-linked antibody (Bangalore GeNei, India) for 2 h. Membrane was then washed thrice for 15 min, and then the protein-antibody complexes were detected by the addition of diaminobenzidine as a substrate.
Reverse transcriptase polymerase chain reaction
Briefly, after treatment of PC12 cells with 3-NP and naringin for desired time period, the medium was removed. The cells were washed with 1 ml of PBS, and then 700 µl of Trizol reagent was added to harvest the cells. After harvesting, 200 µl of chloroform was added; the samples were covered tightly and shaken vigorously for 15 s and allowed to stay on ice for 15 min. Then, the complementary DNAs (cDNA) were synthesized using AuPreP TM Gold cDNA (Life Technologies Pvt. Ltd., Delhi, India) according to the manufacturer’s instructions. The polymerase chain reactions (PCR) were performed using PCR Master Mix (GeNet Bio, Chungnam, Korea) with specific primers listed in Table 1. The PCR products were resolved in 1.4 % agarose gel. The gene expressions were shown as the ratio of densitometric value between target mRNA and glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
Statistical methods
All the data were statistically evaluated with Statistical Package for Social Sciences (SPSS.10) software. Hypothesis testing method included one-way analysis of variance (ANOVA) followed by least significant difference (LSD) test. All the results were expressed as mean ± SD. The ‘p’ value of less than 0.05 was considered to indicate statistical significance.
Results
Dose- and time-dependent effect of 3-NP on cell viability
The dose- and time-dependent 3-NP toxicity was evaluated by determining the reduction of MTT upon incubation of differentiated PC12 cells for 0–40 h with increasing 3-NP concentrations (1–25 mM). As shown in Fig. 1, increasing the 3-NP concentration decreases cell viability in a dose- and time-dependent manner. The viability of PC12 cells was observed to be reduced to 60 % by 15 mM of 3-NP, 16 h after treatment and more drastically at 24 h. Further, increasing the concentration of 3-NP also reduces the cell viability, but there was no significant difference compared to 15 mM concentration. Hence, the induction of PC12 cells with 15 mM of 3-NP for 24 h was followed for further studies.
Protective effect of naringin on 3-NP-induced neurotoxicity
To test whether naringin could reduce the cell death in PC12 cells during 3-NP administration, MTT reduction assay was performed. The cells were treated with 1–20 µM of naringin 1 h prior to the 3-NP exposure and incubated for 24 h. As shown in Fig. 2, naringin at the concentration of 10 µM protected the PC12 cells from 3-NP toxicity (p < 0.05).
Effect of 3-NP and naringin on LDH activity
LDH is an enzyme found in the cells of many tissues, including brain, which catalyzes the interconversion of lactate to pyruvate. LDH is often used as a marker to detect cellular damage during toxic insults [43]. Figure 3 shows the effect of naringin on 3-NP-induced LDH release from PC12 cells. Increased LDH release was observed in 3-NP-induced PC12 cells (p < 0.05) as compared to control. Treatment with naringin significantly decreased the LDH activity towards normal (p < 0.05) as compared to 3-NP-induced cells.
Naringin enhances the antioxidant status
The activation of endogenous antioxidant defense system by flavonoids has attracted special attentions, besides the direct quenching effect on ROS. The activities/level of enzymatic and non-enzymatic antioxidant in 3-NP and naringin-treated PC12 cells are shown in Table 2. The activities of SOD, CAT, GPx, and GR, and the level of GSH were decreased in 3-NP-induced cells (p < 0.05) as compared to control. Treatment with naringin significantly ameliorated these antioxidants in 3-NP-induced cells (p < 0.05) and exhibits its protective effect.
Naringin decreases the lipid peroxidation in 3-NP-induced PC12 cells
One of the consequences of oxidative stress is increase in LPO, which is caused by an attack of free radicals on cell membrane lipids. LPO is known to exert deleterious effects on neuronal membrane integrity and fluidity [44]. 3-NP caused an intense oxidative stress characterized by increase in LPO product. Figure 4 shows the effect of naringin on 3-NP-induced LPO in PC12 cells. Treatment with naringin renders protection to PC12 cells by reducing the level of LPO (p < 0.05), which was elevated upon 3-NP administration. Naringin-alone treated cells show similar effect as of control.
Naringin reduces the 3-NP-induced ROS generation
Oxidative stress refers to an imbalance between the production of free radicals and the ability of cells to defend against them. There is growing evidence implicating oxidative stress as the major cause of cellular injury in variety of human diseases including neurodegenerative disease [45]. Figure 5A shows the ROS generation in 3-NP- and naringin-treated PC12 cells. Administration of PC12 cells with 3-NP resulted in an elevated ROS production (p < 0.05) compared to control. Treatment with naringin defended the PC12 cells by decreasing the 3-NP-induced ROS accumulation (p < 0.05) through its antioxidant property.
Naringin protects against 3-NP-induced mitochondrial dysfunction
Mitochondria are the vulnerable target for various toxicants because of their important role in maintaining cellular integrity and function. The functional alterations occur in mitochondria are due to the changes in mitochondrial membrane potential. Disruption of the mitochondrial membrane potential (i.e., depolarization) is one of the earliest indicators of cellular disturbance. Protective effect of naringin was examined on 3-NP-induced mitochondrial depolarization in PC12 cells. As shown in Fig. 5B, the administration of PC12 cells with 3-NP significantly depolarizes mitochondria (p < 0.05) compared to control. Naringin treatment augmented the mitochondrial membrane polarization in the cells exposed to 3-NP (p < 0.05) and exhibits its protective effect against 3-NP-induced mitochondrial dysfunction.
The activities of mitochondrial respiratory chain enzymes are presented in Fig. 6. The activities of succinate dehydrogenase and cytochrome c oxidase were decreased in 3-NP-induced cells compared to control. Naringin treatment ameliorated the activities of these enzymes in 3-NP-induced PC12 cells.
Anti-apoptotic effect of naringin on 3-NP-induced PC12 cells
Apoptosis is a highly organized form of cell death that is common in variety of biological processes and pathological conditions. Aberrant apoptosis has been implicated in the pathogenesis of neurodegenerative diseases caused by protein misfolding [46]. There is rising evidence suggesting the role of apoptosis in 3-NP-induced HD [47]. To study the anti-apoptotic effect of naringin, RT-PCR analyses of B-cell lymphoma 2 (Bcl-2) and Bcl-2-associated X protein (Bax) were performed in PC12 cells. Figure 7 shows that 3-NP exposure increased the mRNA expression of Bax with decrease in Bcl-2 expression (p < 0.05) as compared to control. Naringin modulated the expressions of Bcl-2 and Bax towards normal level in the cells exposed to 3-NP (p < 0.05), showing its anti-apoptotic effect.
Naringin activates Nrf2 signaling pathway
The facts that ROS lead to neurodegeneration and antioxidant therapy has neuroprotective effects in HD may point to a potential beneficial effect of the Nrf2 pathway. To investigate whether naringin treatment in PC12 cells regulates key proteins involved in the cellular response to oxidative stress, Nrf2 activation was analyzed. Figure 8 shows that 3-NP-induced PC12 cells had minor increase in the Nrf2 activation as compared to control. Naringin treatment exhibited significant increase in the nuclear accumulation of Nrf2 in 3-NP-induced cells (p < 0.05).
Figure 9 shows the mRNA expressions of NAD(P)H:quinone oxidoreductase-1 (NQO-1) and heme oxygenase-1 (HO-1) in 3-NP- and naringin-treated PC12 cells. Minor increase in the expressions of NQO-1 and HO-1 was observed in 3-NP-induced cells compared to control. Administration of naringin significantly increased the expressions of these genes and renders protection against 3-NP-induced neurotoxicity (p < 0.05), which shows that naringin activates the Nrf2 signaling pathway and exhibits protection to 3-NP-induced cells.
PI-3K/Akt signaling was reported to involved in the activation of Nrf2 and up-regulation of several antioxidant gene expression [16]. Further, the activation of Akt by naringin was well documented in earlier study [28]. In this study, we investigated the involvement of PI-3K/Akt signaling in naringin-driven activation of Nrf2 using LY294002, the pharmacological inhibitor of PI-3K/Akt signaling cascade. As shown in Figs. 10 and 11, naringin-induced Nrf2 nuclear translocation and its target genes NQO-1 and HO-1 expressions were significantly reduced by LY294002 suggesting that PI-3K/Akt signaling is involved in the activation of Nrf2 in PC12 cells.
Discussion
Attenuation of oxidative stress and mitochondrial dysfunction protects against neurodegenerative disease [48]. Induction of endogenous antioxidant genes by the transcription factor Nrf2 is considered as the major regulator of redox homeostasis. This is a promising strategy to combat oxidative stress [49]. In this study, the protective effect of naringin on 3-NP-induced neurotoxicity through the PI-3K/Akt-mediated Nrf2 activation in PC12 cells was investigated.
LDH release is an index of cell membrane integrity. LDH activity was measured to determine the protective effect of naringin on 3-NP-induced neurotoxicity in PC12 cells. 3-NP-induced oxidative damage has been characterized by detrimental changes in the LDH activity, resulting in reduction of cell viability. The LDH activity was found to be increased after 3-NP administration. The loss of intracellular LDH and its release into the culture medium is an indicator of cell death due to cell membrane damage induced by 3-NP [50]. Naringin decreased the LDH release and indicates its protective effect through the maintenance of plasma membrane integrity.
Oxidative stress has been reported in 3-NP-induced neurotoxicity through depleted GSH level, and altered profiles of antioxidant enzymes with elevated levels of ROS [51]. It is essential to scavenge free radicals produced during the metabolism of toxic substances and protect cells from oxidative injuries. Therefore, the effect of naringin on antioxidants was examined. The activities of enzymatic antioxidants and level of GSH were found to be decreased in the cells exposed to 3-NP, whereas treatment with naringin significantly augmented the antioxidants in 3-NP exposed cells. The results of this study demonstrate that naringin reduces oxidative damage in 3-NP-induced neurotoxicity. The protective efficacy of naringin also partly attributed to its ability to enhance the antioxidant status in brain [52].
An increase in the lipid peroxidation is one of the consequences of oxidative stress. Measurement of malondialdehyde (MDA), the most abundant product arising from LPO, has been extensively used as an index of oxidative stress. In this study, 3-NP-induced PC12 cells showed increased level of LPO as similar to the previous report [53]. Naringin treatment decreased the LPO in PC12 cells through its ability to scavenge free radicals produced by the 3-NP.
Oxidative stress is a major deleterious event observed in HD [54]. Excessive generation of ROS induces mitochondrial membrane depolarization, damages the respiratory chain, and induces apoptosis in neurons. ROS overproduction is one of the possible mechanisms for 3-NP-induced neuronal death. Considering the important role of ROS in 3-NP-induced oxidative stress, the effect of naringin on ROS in PC12 cells was investigated. Administration of PC12 cells with 3-NP resulted in an elevated ROS production. Increase in the level of ROS has been documented in cells treated with 3-NP [55]. In this study, naringin protected the PC12 cells by decreasing the 3NP-induced ROS accumulation by its ability to scavenge free radical. Flavonoids have been shown to be effective scavengers of ROS [56]. This data suggest that increase in ROS generation by 3-NP causes cytotoxicity; however, treatment with naringin inhibits the ROS generation, thus rendering protection.
Recent studies have implicated the potential role of mitochondria in cell death mechanisms, since mitochondrial dysfunction results in the release of factors that initiate and amplify numerous signals resulting in apoptosis [57]. Further, mitochondrial dysfunction and concomitant bio-energetic failure can lead to abnormal cellular ionic homeostasis, eventually leading to neuronal death [58]. Several studies have reported the occurrence of mitochondrial dysfunction in brain of HD [59, 60]. In this study, PC12 cells induced with 3-NP exhibited mitochondrial depolarization and decrease in mitochondrial respiratory chain enzymes, succinate dehydrogenase and cytochrome c oxidase activities, and these cells might be undergoing the apoptotic processes as similar to previous report [61]. The naringin treatment protected PC12 cells from mitochondrial damage by ameliorating 3-NP-mediated reduction in mitochondrial transmembrane potential. Further, naringin offered considerable degree of protection against the decrease in mitochondrial complex enzyme activities, suggesting its potential to preserve the integrity of mitochondrial respiratory chain through its antioxidant effect. These results indicate that, 3-NP-induced cell death via mitochondrial dysfunction is decreased by the flavonoid naringin.
The mitochondrial death pathway is regulated by a fine balance between pro-apoptotic and pro-survival Bcl-2 family members [62]. In this study, 3-NP-administered PC12 cells exhibited decreased expression of Bcl-2 with elevated Bax. Naringin treatment decreased the apoptosis by ameliorating the expressions of Bcl-2 and Bax in cells exposed to 3-NP. Naringin has been previously reported to modulate the Bcl-2 genes and protect neurons from apoptosis [63]. Further, studies have shown that, Bcl-2 expression protects PC12 cells from 3-NP-induced mitochondrial dependent apoptosis [64]. This shows that naringin is effective enough to combat the 3-NP-induced cell death.
Activation of Nrf2 can confer significant protection to neurons, and drugs that activate this pathway have efficacy in blocking neuronal death [65, 66]. Certainly, a recent work has demonstrated that treatment with flavonoid could activate the Nrf2 pathway and confer protection against neurodegenerative diseases [67]. In the present study, increased Nrf2 nuclear accumulation was observed in naringin-treated cells. Thus, the assenting neuroprotective effect of naringin on 3-NP-induced neurotoxicity is through the modulation of Nrf2-signaling pathway. The induction of protective enzyme defense systems is important for defending cells from oxidative damage. The increased expressions of NQO-1 and HO-1 provide protection against ROS as a part of an adaptive response [68]. In this study, naringin-treated cells showed increased expressions of NQO-1 and HO-1 compared with 3-NP-induced cells, demonstrating that naringin reduces oxidative damage in PC12 cells induced by 3-NP with increased expressions of NQO-1 and HO-1 through Nrf2 activation.
The molecular mechanism underlying the Nrf2 activation by naringin has been the subject of extensive investigations. The PI-3K/Akt is a key survival-promoting signaling pathway that enhances cellular tolerance against multiple apoptotic insults [17, 69]. PI-3K/Akt-mediated Nrf2 activation determines the signals to govern the cellular defense system against inflammatory and oxidative insults [17]. Both P-I3K/Akt and Nrf2 pathways are implicated in the transcriptional regulation of NQO-1 and HO-1 [70]. Naringin was previously reported to activate PI-3K/Akt signaling [28]. In this study, inhibition of PI-3K by specific inhibitor LY294002 reduced the naringin-induced accumulation of Nrf2 in nucleus, and NQO-1 and HO-1 expression. These findings suggest that PI-3K/Akt signaling pathway is required for naringin-mediated Nrf2 activation, and subsequent expression of NQO-1 and HO-1 in PC12 cells.
Appending the results obtained from this study, a mechanism involved in the protective efficacy of naringin against the 3-NP-induced neurotoxicity is demonstrated. This study provides evidence that naringin exhibits neuroprotective effect on 3-NP-induced neurotoxicity through the PI-3K/Akt-dependent Nrf2 activation in PC12 cells.
References
Huang LS, Sun G, Cobessi D, Wang AC, Shen JT, Tung EY, Anderson VE, Berry EA (2006) 3-Nitropropionic acid is a suicide inhibitor of mitochondrial respiration that, upon oxidation by complex II, forms a covalent adduct with a catalytic base arginine in the active site of the enzyme. J Biol Chem 281:5965–5972
Shivasharan BD, Nagakannan P, Thippeswamy BS, Veerapur VP, Bansal P, Unnikrishnan MK (2013) Protective effect of Calendula officinalis Linn. flowers against 3-nitropropionic acid induced experimental Huntington’s disease in rats. Drug Chem Toxicol 36:466–473
Hannan AJ (2005) Novel therapeutic targets for Huntington’s disease. Expert Opin Ther Targets 9:639–650
Tsang TM, Haselden JN, Holmes E (2009) Metabonomic characterization of the 3-nitropropionic acid rat model of Huntington’s disease. Neurochem Res 34:1261–1271
Tasset I, Pontes AJ, Hinojosa AJ, de la Torre R, Túnez I (2011) Olive oil reduces oxidative damage in a 3-nitropropionic acid-induced Huntington’s disease-like rat model. Nutr Neurosci 14:106–111
Federico A, Cardaioli E, Da Pozzo P, Formichi P, Gallus GN, Radi E (2012) Mitochondria, oxidative stress and neurodegeneration. J Neurol Sci 322:254–262
Damiano M, Diguet E, Malgorn C, D’Aurelio M, Galvan L, Petit F, Benhaim L, Guillermier M, Houitte D, Dufour N, Hantraye P, Canals JM, Alberch J, Delzescaux T, Déglon N, Beal MF, Brouillet E (2013) A role of mitochondrial complex II defects in genetic models of Huntington’s disease expressing N-terminal fragments of mutant huntingtin. Hum Mol Genet 22:3869–3882
Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787–795
Browne SE, Ferrante RJ, Beal MF (1999) Oxidative stress in Huntington’s disease. Brain Pathol 9:147–163
Quintanilla RA, Johnson GV (2009) Role of mitochondrial dysfunction in the pathogenesis of Huntington’s disease. Brain Res Bull 80:242–247
Hariharan A, Shetty S, Shirole T, Jagtap AG (2014) Potential of protease inhibitor in 3-nitropropionic acid induced Huntington’s disease like symptoms: mitochondrial dysfunction and neurodegeneration. Neurotoxicology 45:139–148
Baird L, Dinkova-Kostova AT (2011) The cytoprotective role of the Keap1–Nrf2 pathway. Arch Toxicol 85:241–272
de Vries HE, Witte M, Hondius D, Rozemuller AJ, Drukarch B, Hoozemans J, van Horssen J (2008) Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease? Free Radic Biol Med 45:1375–1383
Kumar H, Koppula S, Kim IS, More SV, Kim BW, Choi DK (2012) Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death. CNS Neurol Disord Drug Targets 11:1015–1029
Tufekci KU, Civi Bayin E, Genc S, Genc K (2011) The Nrf2/ARE pathway: a promising target to counteract mitochondrial dysfunction in Parkinson’s disease. Parkinsons Dis 2011:314082
Na HK, Kim EH, Jung JH, Lee HH, Hyun JW, Surh YJ (2008) (−)-Epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells. Arch Biochem Biophys 476:171–177
Nakaso K, Yano H, Fukuhara Y, Takeshima T, Wada-Isoe K, Nakashima K (2003) PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells. FEBS Lett 546:181–184
Dai J, Mumper RJ (2010) Plant phenolics: extraction, analysis and their antioxidant and anticancer properties. Molecules 15:7313–7352
Leem E, Nam JH, Jeon MT, Shin WH, Won SY, Park SJ, Choi MS, Jin BK, Jung UJ, Kim SR (2014) Naringin protects the nigrostriatal dopaminergic projection through induction of GDNF in a neurotoxin model of Parkinson’s disease. J Nutr Biochem 25:801–806
Qualls Z, Brown D, Ramlochansingh C, Hurley LL, Tizabi Y (2014) Protective effects of curcumin against rotenone and salsolinol-induced toxicity: implications for Parkinson’s disease. Neurotox Res 25:81–89
Golechha M, Sarangal V, Bhatia J, Chaudhry U, Saluja D, Arya DS (2014) Naringin ameliorates pentylenetetrazol-induced seizures and associated oxidative stress, inflammation, and cognitive impairment in rats: possible mechanisms of neuroprotection. Epilepsy Behav 41:98–102
Gopinath K, Prakash D, Sudhandiran G (2011) Neuroprotective effect of naringin, a dietary flavonoid against 3-nitropropionic acid-induced neuronal apoptosis. Neurochem Int 59:1066–1073
Chen Y, Nie YC, Luo YL, Lin F, Zheng YF, Cheng GH, Wu H, Zhang KJ, Su WW, Shen JG, Li PB (2013) Protective effects of naringin against paraquat-induced acute lung injury and pulmonary fibrosis in mice. Food Chem Toxicol 58:133–140
Camargo CA, Gomes-Marcondes MC, Wutzki NC, Aoyama H (2012) Naringin inhibits tumor growth and reduces interleukin-6 and tumor necrosis factor α levels in rats with Walker 256 carcinosarcoma. Anticancer Res 32:129–133
Chanet A, Milenkovic D, Deval C, Potier M, Constans J, Mazur A, Bennetau-Pelissero C, Morand C, Bérard AM (2012) Naringin, the major grapefruit flavonoid, specifically affects atherosclerosis development in diet-induced hypercholesterolemia in mice. J Nutr Biochem 23:469–477
Gopinath K, Sudhandiran G (2012) Naringin modulates oxidative stress and inflammation in 3-nitropropionic acid-induced neurodegeneration through the activation of nuclear factor-erythroid 2-related factor-2 signalling pathway. Neuroscience 227:134–143
Kulasekaran G, Ganapasam S (2015) Protective effect of naringin on 3-nitropropionic acid-induced neurodegeneration through the modulation of matrix metalloproteinases and Glial fibrillary acidic protein. Can J Physiol Pharmacol. doi:10.1139/cjpp-2015-0035
Wu JB, Fong YC, Tsai HY, Chen YF, Tsuzuki M, Tang CH (2008) Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts. Eur J Pharmacol 588:333–341
Yuan J, Lovejoy DB, Richardson DR (2004) Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment. Blood 104:1450–1458
King J (1965) In: Van D (ed) Lactate dehydrogenase in practical clinical enzymology. London, Nostrand, pp 83–93
Marklund S, Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469–474
Sinha AK (1972) Colorimetric assay of catalase. Anal Biochem 47:389–394
Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG (1973) Selenium: biochemical rote as a component of glutathione peroxidase. Science 179:588–590
Staal GE, Visser J, Veeger C (1969) Purification and properties of glutathione reductase of human erythrocytes. Biochem Biophys Acta 185:39–48
Moron MS, Depierre JW, Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 582:67–78
Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358
Moreadith RW, Fiskum G (1984) Isolation of mitochondria from ascites tumor cells permeabilized with digitonin. Anal Biochem 137:360–367
Slater EC, Borner WD Jr (1952) The effect of fluoride on the succinic oxidase system. Biochem J 52:185–196
Mutisya EM, Bowling AC, Beal MF (1994) Cortical cytochrome oxidase activity is reduced in Alzheimer’s disease. J Neurochem 63:2179–2184
Mukherjee SB, Das M, Sudhandiran G, Shaha C (2002) Increase in cytosolic Ca2+ levels through the activation of non-selective cation channels induced by oxidative stress causes mitochondrial depolarization leading to apoptosis-like death in Leishmania donovani promastigotes. J Biol Chem 277:24717–24727
Dey R, Moraes CT (2000) Lack of oxidative phosphorylation and low mitochondrial membrane potential decrease susceptibility to apoptosis and do not modulate the protective effect of Bcl-x(L) in osteosarcoma cells. J Biol Chem 275:7087–7094
Yao P, Nussler A, Liu L, Hao L, Song F, Schirmeier A, Nussler N (2007) Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK/Nrf2 pathways. J Hepatol 47:253–261
Mazzone GL, Nistri A (2011) Delayed neuroprotection by riluzole against excitotoxic damage evoked by kainate on rat organotypic spinal cord cultures. Neuroscience 190:318–327
Farooqui AA, Ong WY, Horrocks LA (2004) Biochemical aspects of neurodegeneration in human brain: involvement of neural membrane phospholipids and phospholipases A2. Neurochem Res 29:1961–1977
Barnham KJ, Masters CL, Bush AI (2004) Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3:205–214
Mattson MP (2000) Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 1:120–129
Rosenstock TR, Carvalho AC, Jurkiewicz A, Frussa FR, Smaili SS (2004) Mitochondrial calcium, oxidative stress and apoptosis in a neurodegenerative disease model induced by 3-nitropropionic acid. J Neurochem 88:1220–1228
Stack EC, Ferro JL, Kim J, Del Signore SJ, Goodrich S, Matson S, Hunt BB, Cormier K, Smith K, Matson WR, Ryu H, Ferrante RJ (2008) Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson’s disease. Biochim Biophys Acta 1782:151–162
van Muiswinkel FL, Kuiperij HB (2005) The Nrf2–ARE signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders. Curr Drug Targets CNS Neurol Disord 4:267–281
Noer H, Kristensen BW, Noraberg J, Zimmer J, Gramsbergen JB (2002) 3-Nitropropionic acid neurotoxicity in hippocampal slice cultures: developmental and regional vulnerability and dependency on glucose. Exp Neurol 176:237–246
Túnez I, Tasset I, Pérez-De La Cruz V, Santamaría A (2010) 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington’s disease: past, present and future. Molecules 15:878–916
Jeon SM, Bok SH, Jang MK, Lee MK, Nam KT, Park YB, Rhee SJ, Choi MS (2001) Antioxidative activity of naringin and lovastatin in high cholesterol-fed rabbits. Life Sci 69:2855–2866
Pérez-De La Cruz V, González-Cortés C, Pedraza-Chaverrí J, Maldonado PD, Andrés-Martínez L, Santamaría A (2006) Protective effect of S-allylcysteine on 3-nitropropionic acid-induced lipid peroxidation and mitochondrial dysfunction in rat brain synaptosomes. Brain Res Bull 68:379–383
Browne SE, Beal MF (2006) Oxidative damage in Huntington’s disease pathogenesis. Antioxid Redox Signal 8:2061–2073
Liot G, Bossy B, Lubitz S, Kushnareva Y, Sejbuk N, Bossy-Wetzel E (2009) Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway. Cell Death Differ 16:899–909
Ishige K, Schubert D, Sagara Y (2001) Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic Biol Med 30:433–446
Ly JD, Grubb DR, Lawen A (2003) The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis 8:115–128
Ott M, Gogvadze V, Orrenius S, Zhivotovsky B (2007) Mitochondria, oxidative stress and cell death. Apoptosis 12:913–922
Oliveira JM (2010) Nature and cause of mitochondrial dysfunction in Huntington’s disease: focusing on huntingtin and the striatum. J Neurochem 114:1–12
Oliveira JM, Jekabsons MB, Chen S, Lin A, Rego AC, Gonçalves J, Ellerby LM, Nicholls DG (2007) Mitochondrial dysfunction in Huntington’s disease: the bioenergetics of isolated and in situ mitochondria from transgenic mice. J Neurochem 101:241–249
Nasr P, Gursahani HI, Pang Z, Bondada V, Lee J, Hadley RW, Geddes JW (2003) Influence of cytosolic and mitochondrial Ca2+, ATP, mitochondrial membrane potential, and calpain activity on the mechanism of neuron death induced by 3-nitropropionic acid. Neurochem Int 43:89–99
Cory S, Adams JM (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2:647–656
Kim HJ, Song JY, Park HJ, Park HK, Yun DH, Chung JH (2009) Naringin protects against rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. Korean J Physiol Pharmacol 13:281–285
Mandavilli BS, Boldogh I, Van Houten B (2005) 3-Nitropropionic acid-induced hydrogen peroxide, mitochondrial DNA damage, and cell death are attenuated by Bcl-2 overexpression in PC12 cells. Mol Brain Res 133:215–223
Calkins MJ, Johnson DA, Townsend JA, Vargas MR, Dowell JA, Williamson TP, Kraft AD, Lee JM, Li J, Johnson JA (2009) The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid Redox Signal 11:497–508
Johnson JA, Johnson DA, Kraft AD, Calkins MJ, Jakel RJ, Vargas MR, Chen PC (2008) The Nrf2–ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Ann N Y Acad Sci 1147:61–69
Scapagnini G, Vasto S, Abraham NG, Caruso C, Zella D, Fabio G (2011) Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol Neurobiol 44:192–201
He X, Chen MG, Ma Q (2008) Activation of Nrf2 in defense against cadmium-induced oxidative stress. Chem Res Toxicol 21:1375–1383
Brunet A, Datta SR, Greenberg ME (2001) Transcription-dependent and -independent control of neuronal survival by the PI3K–Akt signaling pathway. Curr Opin Neurobiol 11:297–305
Martin D, Rojo AI, Salinas M, Diaz R, Gallardo G, Alam J, De Galarreta CM, Cuadrado A (2004) Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J Biol Chem 279:8919–8929
Acknowledgments
We thank Lady Tata Memorial Trust, Mumbai, India and Council of Scientific and Industrial Research, New Delhi, India for financial assistance awarded to KG.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there are no conflicts of interest.
Rights and permissions
About this article
Cite this article
Kulasekaran, G., Ganapasam, S. Neuroprotective efficacy of naringin on 3-nitropropionic acid-induced mitochondrial dysfunction through the modulation of Nrf2 signaling pathway in PC12 cells. Mol Cell Biochem 409, 199–211 (2015). https://doi.org/10.1007/s11010-015-2525-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-015-2525-9